These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 18632521

  • 1. An extended dosing regimen of epoetin alfa 60,000 units every 2 weeks in anemic patients with cancer receiving chemotherapy.
    Gregory SA, Xie J, Szczudlo T, Williams D, Woodman RC, Wilhelm FE.
    Support Cancer Ther; 2007 Sep 01; 4(4):225-32. PubMed ID: 18632521
    [Abstract] [Full Text] [Related]

  • 2. An extended maintenance dosing regimen of epoetin alfa 80,000 U every 3 weeks in anemic patients with cancer receiving chemotherapy.
    Montoya VP, Xie J, Williams D, Woodman RC, Wilhelm FE.
    Support Care Cancer; 2007 Dec 01; 15(12):1385-92. PubMed ID: 17541653
    [Abstract] [Full Text] [Related]

  • 3. An open-label pilot study to evaluate a flexible dosing regimen of epoetin alfa for the treatment of chemotherapy-induced anemia: 60,000 units weekly followed by 60,000 units every 2 weeks.
    Reddy PK, Williams D, Wilhelm FE.
    Support Cancer Ther; 2006 Oct 01; 4(1):56-62. PubMed ID: 18632467
    [Abstract] [Full Text] [Related]

  • 4. Epoetin alfa 60,000 U once weekly followed by 120,000 U every 3 weeks increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy.
    Patton J, Kuzur M, Liggett W, Miranda F, Varsos H, Porter L.
    Oncologist; 2004 Oct 01; 9(1):90-6. PubMed ID: 14755018
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A pilot study to evaluate the safety and clinical outcomes of once-weekly epoetin alfa 80,000 u in anemic patients with cancer receiving chemotherapy.
    Waltzman RJ, Williams D, Braly P.
    Support Cancer Ther; 2005 Oct 01; 3(1):47-53. PubMed ID: 18632436
    [Abstract] [Full Text] [Related]

  • 7. An open-label, randomized, multicenter, controlled study of epoetin alfa for the treatment of anemia of chronic kidney disease in the long term care setting.
    Patel M, Thimons DG, Winston JL, Langholff W, McGowan T.
    J Am Med Dir Assoc; 2012 Mar 01; 13(3):244-8. PubMed ID: 21450214
    [Abstract] [Full Text] [Related]

  • 8. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
    Voravud N, Sriuranpong V.
    J Med Assoc Thai; 2005 May 01; 88(5):607-12. PubMed ID: 16149676
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of epoetin alfa administered every 2 weeks to maintain hemoglobin and quality of life in anemic HIV-infected patients.
    Levine AM, Salvato P, Leitz GJ, Champs 2 Study Group.
    AIDS Res Hum Retroviruses; 2008 Feb 01; 24(2):131-9. PubMed ID: 18284320
    [Abstract] [Full Text] [Related]

  • 10. Weekly epoetin alfa during adjuvant chemotherapy for breast cancer: effect on hemoglobin levels and quality of life.
    Hudis CA, Vogel CL, Gralow JR, Williams D, Procrit Study Group.
    Clin Breast Cancer; 2005 Jun 01; 6(2):132-42. PubMed ID: 16001991
    [Abstract] [Full Text] [Related]

  • 11. Randomized, open-label comparison of epoetin alfa extended dosing (80 000 U Q2W) vs weekly dosing (40 000 U QW) in patients with chemotherapy-induced anemia.
    Henry DH, Gordan LN, Charu V, Wilhelm FE, Williams D, Xie J, Woodman RC.
    Curr Med Res Opin; 2006 Jul 01; 22(7):1403-13. PubMed ID: 16834839
    [Abstract] [Full Text] [Related]

  • 12. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
    Voravud N, Sriuranpong V, Suwanrusme H.
    J Med Assoc Thai; 2007 Jun 01; 90(6):1082-8. PubMed ID: 17624200
    [Abstract] [Full Text] [Related]

  • 13. Treatment of chemotherapy-induced anemia in breast cancer: results of a randomized controlled trial of darbepoetin alfa 200 microg every 2 weeks versus epoetin alfa 40,000 U weekly.
    Senecal FM, Yee L, Gabrail N, Charu V, Tomita D, Rossi G, Schwartzberg L.
    Clin Breast Cancer; 2005 Dec 01; 6(5):446-54. PubMed ID: 16381629
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness and safety of an induction therapy with epoetin alfa in anemic cancer patients receiving concomitant chemotherapy.
    Cortesi E, Mancuso A, De Pasquale Ceratti A, Pizzardi N, D'Auria G, Accettura C, Beccaglia P, Bertelletti D, De Marinis F.
    Oncologist; 2004 Dec 01; 9(4):459-68. PubMed ID: 15266099
    [Abstract] [Full Text] [Related]

  • 15. Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy.
    Shasha D, George MJ, Harrison LB.
    Cancer; 2003 Sep 01; 98(5):1072-9. PubMed ID: 12942577
    [Abstract] [Full Text] [Related]

  • 16. A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: an open-label, non randomized, pilot study.
    Santini D, Vincenzi B, La Cesa A, Virzi V, Navajas F, Malafarina V, Dicuonzo G, Cassandro R, Esposito V, Montesarchio V, Groeger AM, Tonini G.
    Anticancer Res; 2005 Sep 01; 25(1B):669-74. PubMed ID: 15816644
    [Abstract] [Full Text] [Related]

  • 17. Extended epoetin alfa dosing in chronic kidney disease patients: a retrospective review.
    Germain M, Ram CV, Bhaduri S, Tang KL, Klausner M, Curzi M.
    Nephrol Dial Transplant; 2005 Oct 01; 20(10):2146-52. PubMed ID: 15985516
    [Abstract] [Full Text] [Related]

  • 18. Comparing the efficacy and safety of fixed versus weight-based dosing of epoetin alpha in anemic cancer patients receiving platinum-based chemotherapy.
    Granetto C, Ricci S, Martoni A, Pezzella G, Testore F, Mattioli R, Lampignano M, Tacconi F, Porrozzi S, Gasparini G, Mantovani G, EPO-ITA3 Study Group.
    Oncol Rep; 2003 Oct 01; 10(5):1289-96. PubMed ID: 12883695
    [Abstract] [Full Text] [Related]

  • 19. Once-weekly epoetin alfa for treating the anemia of chronic kidney disease.
    Provenzano R, Garcia-Mayol L, Suchinda P, Von Hartitzsch B, Woollen SB, Zabaneh R, Fink JC, POWER Study Group.
    Clin Nephrol; 2004 Jun 01; 61(6):392-405. PubMed ID: 15224803
    [Abstract] [Full Text] [Related]

  • 20. Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study.
    Abdelrazik N, Fouda M.
    Hematology; 2007 Dec 01; 12(6):533-41. PubMed ID: 17852440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.